Guardant Health announced that the FDA has approved its Guardant360 CDx blood test as a companion diagnostic for Eli Lilly’s Inluriyo, enabling the identification of advanced breast cancer patients ...
Genome sequencing is a comprehensive genetic test that is being integrated into health care systems internationally. Test indications include suspected genetic disorders in children and adults for ...
Winner of the 2025 ADA Innovation of the Year Award, unlocking a $2B+ diagnostics market with virtually no direct competitors. ST. AUGUSTINE, Fla.--( ...
New York, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Covid Rapid Diagnostic Test Market - Growth, Trends, Covid-19 Impact ...
Background: Sensitivity and specificity are characteristics of a diagnostic test and are not expected to change as the prevalence of the target condition changes. We sought to evaluate the association ...
Scientists leading the trial at University College London believe the blood test could improve the accuracy of diagnosis of the disease to more than 90%.
Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for ...
Community Diagnostic Centres are slashing cancer diagnosis times, helping patients get faster answers and earlier access to ...
Two new reports from the World Health Organization (WHO) suggest that the development of new treatments and tests for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback